CLINICAL_TRIALS
ClinicalTrials.gov record update
Longitudinal Investigation of Imidazoline-2 Binding Site as a Novel Marker of Disease Progression in Parkinson's Disease: An [11C]BU99008 PET Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05516719
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:12.626176+00:00
- Published At
- 2025-10-07T00:00:00+00:00
- Record Updated At
- 2025-10-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Parkinson\u0027s", "Parkinson Disease", "Parkinson\u0027s Disease", "Neurodegenerative Diseases", "Neurodegeneration", "Positron Emission Tomography"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-07"- protocolSection.identificationModule.nctId
"NCT05516719"- protocolSection.identificationModule.officialTitle
"Longitudinal Investigation of Imidazoline-2 Binding Site as a Novel Marker of Disease Progression in Parkinson\u0027s Disease: An [11C]BU99008 PET Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.